Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
(3S,6S,9S,12S,15S,18S,21S,24S,27S)-3-((6S,9S,12S,15S,18S,21S,24S,27S,30S,33S)-1-amino-18-(2-amino-2-oxoethyl)-21-sec-butyl-6-((S)-2-((S)-1-((S)-1-carboxy-2-(4-hydroxyphenyl)ethylamino)-5-guanidino-1-oxopentan-2-ylcarbamoyl)pyrrolidine-1-carbonyl)-27,30-bis(3-guanidinopropyl)-24-(4-hydroxybenzyl)-9-((R)-1-hydroxyethyl)-1-imino-12-isobutyl-35-methyl-15-(2-(methylthio)ethyl)-8,11,14,17,20,23,26,29,32-nonaoxo-2,7,10,13,16,19,22,25,28,31-decaazahexatriacontan-33-ylcarbamoyl)-27-((S)-1-((6S,9S,12S,15S)-9-(2-amino-2-oxoethyl)-1-((S)-1-((S)-2-((S)-2-((S)-1-((S)-2-((S)-2-((S)-1-((S)-2-aminopropanoyl)pyrrolidine-2-carboxamido)-4-methylpentanamido)-4-carboxybutanoyl)pyrrolidine-2-carboxamido)-3-methylbutanamido)-3-(4-hydroxyphenyl)propanoyl)pyrrolidin-2-yl)-6-(carboxymethyl)-15-((R)-1-hydroxyethyl)-12-methyl-1,4,7,10,13-pentaoxo-2,5,8,11,14-pentaazahexadecane)pyrrolidine-2-carboxamido)-15,24-bis(3-amino-3-oxopropyl)-12-(4-hydroxybenzyl)-6,9,18-trimethyl-21-(2-(methylthio)ethyl)-5,8,11,14,17,20,23,26-octaoxo-4,7,10,13,16,19,22,25-octaazatriacontane-1,30-dioic acid
ID: ALA4276961
Chembl Id: CHEMBL4276961
PubChem CID: 145985176
Max Phase: Preclinical
Molecular Formula: C185H286N52O55S2
Molecular Weight: 4182.77
Molecule Type: Unknown
Associated Items: